Polaris AI Pharma

폴라리스AI파마 · 041910

Health Care Pharmaceuticals · KOSDAQ

Small-cap

Market cap US$55.3M (₩76.4B)

Overview

Polaris AI Pharma is a pharmaceutical company listed on KOSDAQ, South Korea's tech and small-cap stock exchange.

The filing's business description is largely a table of contents without substantive product or operational detail, so the specific medicines or health-care products it supplies, and the customers it serves, cannot be confirmed from the available text.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025
Revenue · FY2025
US$40.2M
▼ −6.8% YoY
Operating profit · FY2025
US$2.3M
▲ +1712.2% YoY
Net income · FY2025
US$4.5M
▲ +56.1% YoY

Revenue

  • FY2023US$46.5M
  • FY2024US$43.2M
  • FY2025US$40.2M

Operating profit

  • FY2023US$3.9M
  • FY2024US$127.5K
  • FY2025US$2.3M

Net income

  • FY2023US$2.8M
  • FY2024US$2.9M
  • FY2025US$4.5M

Key ratios (FY2025)

ROE
4.5%
Debt/Eq
44.1%
Op. margin
5.7%
Net margin
11.1%
Rev. YoY
▼ −6.8%

Price charts coming soon

Interactive price history isn't here yet. Would you use it?

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-06-12 (KST). · FX: 1 USD ≈ ₩1,380 (2026-06-01).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.